Liposuction and diabetes type 2 development risk reduction in the obese patient

Medical Hypotheses

Volumn 68, Issue 2, 2007, Pages 393-396

  Perez, R A ^a  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE COURSE; HUMAN; HYPOTHESIS; INSULIN SENSITIVITY; LIPOSUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK REDUCTION;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; HUMANS; LIPECTOMY; OBESITY; RISK FACTORS;

EID: 33845322586     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.06.048     Document Type: Article

References (31)

1. National Center for Health Statistics. Prevalence of overweight and obesity among adults: United States, 2003-2004. Available from: http://www.cdc.gov/nchs/. Accessed May 2006.
2. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723
3. American Obesity Association. Available from: http://www.obesity.orgAccessed May 2006.
4. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531
5. Kuczmarski R.J., Flegal K.M., Campbell S.M., and Johnson C.L. Increasing prevalence of overweight among US adults: The national health and nutrition examination surveys, 1960-1991. JAMA 272 (1994) 205
6. National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obes Res 6: 51S, 1998.
7. Allison D.B., Fontaine K.R., Manson J.E., et al. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530
8. Tuomilehto J., Lindstrom J., Ericksson J.G., Valle T.T., Hamalainen H., Ilanne-Parika P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344 (2001) 1343-1350
9. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403.
10. Mayfield J. Diagnosis and classification of diabetes mellitus: New Criteria. Am Family Phys 1998;58 (6).
11. Matarasso A., and Hutchinson O.H.Z. Liposuction. JAMA 285 (2001) 266-268
12. Ahima R.S., and Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11 (2000) 327
13. Kelley D.E., Thaete F.L., Troost F., Huwe T., and Goodpaster B.H. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 278 (2000) E941-E948
14. Johnson D., Cormack G.C., Abrahams P.H., and Dixon A.K. Computed tomographic observations on subcutaneous fat: Implications for liposuction. Plast Reconstruct Surg 97 (1996) 387-396
15. Sheehan M.T., and Jensen M.D. Metabolic complications on obesity. Pathophysiologic considerations. Med Clin North America 84 (2000) 363-385
16. Bouret S.G., and Simerly R.B. Leptin and development of hypothalamic feeding circuits. Endocrinology 145 (2004) 2521
17. Hoffstedt J., Arvidsson E., Sjolin E., Wahlen K., and Arner P. Adipose tissue adiponectin production and adiponectinserum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89 (2004) 1391-1396
18. Valsamakis G., McTernan Pg P., Chetty R., Al Daghri N., Field A., Hanif W., Barnett Ah A., and Kumar S. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 53 (2004) 430-434
19. Voros G., Maquoi E., Collen D., and Lijnen H.R. Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism. J Thromb Haemost 2 (2004) 507-513
20. D'Andrea F., Grella R., Rizzo M.R., Grella E., Grella R., Nicoletti G., et al. Changing the metabolic profile by large-volume liposuction: A clinical study conducted with 123 obese women. Aesth Plast Surg 29 (2005) 472-478
21. Davis DA, Pellowski DM, Davis DA and Donahoo WT: Acute and 1-month effect of small-volume suction lipectomy on insulin sensitivity and cardiovascular risk. Int J Obesity (advance online publication 7 March 2006), 2006.
22. Schreiber J.E., Singh N.K., and Shermak M.A. The effect of liposuction and diet on ghrelin, adiponectin, and leptin levels in obese zucker rats. Plastic Reconstr Surg 117 6 (2006) 1829-1835 May
23. Espelund U., Hansen T., orskov H., and Frystyk J. Assessment of ghrelin. APMIS Suppl 109 (2003) 140
24. Wren A., Seal L., Cohen M., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992
25. Sanger C., and David L.R. Impact of significant weight loss on outcome of body-contouring surgery. Ann Plast Surg 56 (2006) 1
26. Klein S., Fontana L., Young V.L., Coggan A.R., Kilo C., Patterson B.W., and Mohammed B.S. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 25 (2004) 2549
27. Busetto L., Bassetto F., and Nolli M. Metabolic effects of liposuction: Yes or no. N Engl J Med 351 (2004) 1355
28. Giese SY, Bulan EJ, Commons GW, et al.: Improvements in cardiovascular risk profile with large-volume liposuction: A pilot study Plast Reconstr Surg 108:510, discussion 520, 2001.
29. Giugliano G., Nicoletti G., Grella E., et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57 (2004) 190
30. Gonzalez-Ortiz M., Robles-Cervantes J.A., Cardenas-Camarena L., et al. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women alter large-volume liposuction treatment. Horm Metab Res 34 (2002) 446
31. Robles-Cervantes J.A., Yanez-Diaz S., and Cardenas-Camarena L. Modification of insulin, glucosa, and cholesterol levels in nonobese women undergoing liposuction. Ann Plast Surg 52 (2004) 64